@article{a74718f97e30427c8df9c4b9afeef329,
title = "Troponin in Stable Patients Undergoing Coronary Angiography: Should It Be Routinely Assessed?",
keywords = "Editorials, coronary angiography, troponin",
author = "Alessandro Spirito and Rebecca Cohen and Roxana Mehran",
note = "Funding Information: Dr Spirito received a research grant from the Swiss National Science Foundation. Dr Mehran reports the following outside of the submitted work: institutional research payments from Abbott, Abiomed, Alleviant Medical, AM-Pharma, Amgen, Arena, AstraZeneca, Atricure, Bayer, Biosensors, Biotronik, Boston Scientific, Bristol-Myers Squibb, CardiaWave, CeloNova, Chiesi, Concept Medical, CSL Behring, Cytosorbents, Daiichi Sankyo, Element Science, Faraday, Humacyte, Idorsia Pharmaceuticals, Janssen, Medtronic, Novartis, OrbusNeich, PhaseBio, Philips, Pi-Cardia, RenalPro, Shockwave, Vivasure, and Zoll; personal fees from Cine-Med Research and WebMD; equity <1\% in Applied Therapeutics, Elixir Medical, Stel, and ControlRad (spouse); Scientific Advisory Board for American Medical Association, American College of Cardiology (Board of Trustees Member), Society for Cardiovascular Angiography and Interventions (Women in Innovations Committee Member), and JAMA Associate Editor; and Faculty Cardiovascular Research Foundation (no fee). R. Cohen has no disclosures to report.",
year = "2022",
month = sep,
day = "6",
doi = "10.1161/JAHA.122.027297",
language = "English",
volume = "11",
journal = "Journal of the American Heart Association",
issn = "2047-9980",
publisher = "American Heart Association Inc.",
number = "17",
}